Glutathione‐Triggered Synergistically Enhanced Dual‐Modality Magnetic Resonance Imaging for Tumor Diagnosis
Small · 17.11.2026
DOI: 10.1002/smll.76749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 17.11.2026. Verfasst von Wenyue Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First Pe…. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of China, Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Accurate identification of malignant tumors by magnetic resonance imaging (MRI) remains a critical challenge, as the current clinical contrast agents lack sufficient sensitivity and specificity. Herein, a tumor microenvironment (TME)‐triggered synergistically enhanced T 1 ‐weighted imaging ( T 1 WI) and susceptibility‐weighted imaging (SWI) strategy has been developed using NaGdF 4 nanoprobes. The nanoprobe is strategically designed with a glutathione (GSH)‐cleavable disulfide bond (─S─S─) as the key responsive moiety, together with an RGD peptide sequence and a stealth self‐peptide sequence for active tumor vascular targeting and prolonged blood circulation, respectively. When the nanoprobes are exposed to the abnormally high GSH level in the TME, the cleavage of ─S─S─ induces crosslinking with unreacted maleimide groups on nanoprobes surface, inducing aggregation and magnetic coupling of nanoprobes. This aggregation mainly prolongs rotational correlation time ( τ R ) to enhance T 1 signals, while simultaneously amplifying local magnetic field inhomogeneity resulting in strengthened SWI signals. The activatable nanoprobes exhibit significantly amplified T 1 /SWI dual‐modality signals compared with non‐responsive controls on 4T1 tumor‐bearing mouse models. This study demonstrates that TME‐triggered enhancement of dual‐modality MRI signals overcomes the insufficient tumor contrast and the inherent relaxivity trade‐offs of conventional agents, offering a robust strategy for designing next‐generation activatable nanoprobes for accurate tumor MRI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, China.
- College of Materials Science and Engineering, and College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
- Department of Radiology, China-Japan Friendship Hospital, Beijing, China.
- Department of Psychiatry and Center for Preclinical Safety Evaluation of Drugs, West China Hospital of Sichuan University, Chengdu, China.
Förderung
- Natural Science Foundation of China
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Li, W., Ren, X., Wu, S., Ma, Y., Wu, S., Jiang, Y., Qin, M., Lan, Y., & Hou, Y. (2026). Glutathione‐Triggered Synergistically Enhanced Dual‐Modality Magnetic Resonance Imaging for Tumor Diagnosis. Small. https://doi.org/10.1002/smll.76749
Vancouver
Li W, Ren X, Wu S, Ma Y, Wu S, Jiang Y, et al. Glutathione‐Triggered Synergistically Enhanced Dual‐Modality Magnetic Resonance Imaging for Tumor Diagnosis. Small. 2026. doi:10.1002/smll.76749
BibTeX
@article{Li2026,
author = {Li, Wenyue and Ren, Xinyu and Wu, Shuai and Ma, Yuqiang and Wu, Sitong and Jiang, Yanjiao and Qin, Meng and Lan, Yue and Hou, Yi},
title = {Glutathione‐Triggered Synergistically Enhanced Dual‐Modality Magnetic Resonance Imaging for Tumor Diagnosis},
journal = {Small},
year = {2026},
doi = {10.1002/smll.76749}
}
EUVIMED